Assistant Professor, Pediatric Hematology and Oncology, Baylor College of Medicine
Pediatric Hematology & Oncology
Dr. Peter E. Zage, MD
|
|
Give Review
Doctor Peter E. Zage, MD works in the field of Pediatric Hematology & Oncology. He went to medical school at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is one of the top medical schools in the US. Columbia University College of Physicians & Surgeons is ranked 8/52 in Research/PrimaryCare. Peter Zage is a published MD as well. He has 31 publications published. The latest was: The membrane proximal region of the integrin beta cytoplasmic domain can mediate oligomerization.
Publications
- A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.
- Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition.
- The novel kinase inhibitor EMD1214063 is effective against neuroblastoma.
- Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies.
- Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter⢠system.
- UBE4B couples ubiquitination and sorting machineries to enable EGFR degradation.
- Congenital Neuroblastoma in a Neonate With Isotretinoin Embryopathy.
- UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth fact...
- New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.
- Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience.
- Notch pathway activation induces neuroblastoma tumor cell growth arrest.
- The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan.
- The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma.
- Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo.
- A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhi...
- Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway.
- Outcomes of a two-drug chemotherapy regimen for intraocular Retinoblastoma.
- Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikina...
- Integrins interact with focal adhesions through multiple distinct pathways.
- The membrane proximal region of the integrin beta cytoplasmic domain can mediate oligomerization.
- Measuring cytotoxicity: a new perspective on LC50.
- Predicting tumor cell repopulation after response: mathematical modeling of Cancer cell growth.
- SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
- Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.
- Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
- Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group.
- Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines.
- Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations.
- Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(?-TRCP) in neuroblastoma cells.
- Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B.
Schools
Columbia Univ Coll Of Physicians and Surgeons
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Osteosarcoma
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
McGaw Medical Center of Northwestern University -
University of Chicago -
Columbia University College of Physicians & Surgeons
Hospital
-
Texas Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Kenneth McClain, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nidale G. Tarek, MD
This Doctor is OpenDoctor Recommended.
|